Jiksak Bioengineering is pleased to announce that the research and development project titled “Development of a Novel Therapeutic for Distal Hereditary Motor Neuropathy Type 7” has been selected for funding under the FY2026 Program for Research on Intractable Diseases by the Japan Agency for Medical Research and Development (AMED).
This project will be conducted under the leadership Professor Yohei Iguchi, Lecturer and Group Leader at Nagoya University. As part of this project, Jiksak will contribute its proprietary Neuron DDS platform to support the development of targeted therapeutic approaches. Jiksak remains committed to advance innovative solutions for intractable diseases and accelerate the translation of innovative therapeutic approaches through collaborations with leading academic institutions.